The majority of studies on human cell lines have shown a positive modulation of PON1 activity in response to atorvastatin, and a similar effect was reported for simvastatin and pivastatin [206,207], while one study on human hepatoma cells reported a decrease in PON1 activity [208]. This evidence concerns the gene PON1 and hepatocellular carcinoma.